Nuritas and Nestlé to Work Together on Discovery of Food-Derived Bioactive Peptides Through Artificial Intelligence
Nuritas, the Irish biotechnology company, and Nestlé have entered into a collaboration aiming at discovering bioactive peptide networks within specific target areas of significant value. In order to achieve the common goal, Nuritas will deploy its award-winning and novel technology platform, which uses Artificial Intelligence and DNA analysis to predict, unlock, and validate highly efficacious peptides, exclusively from natural food sources. Nestlé will use their considerable scientific know-how and applications expertise to validate the efficacy of these new discoveries within the target applications.
“At Nuritas our mission is to positively impact billions of lives worldwide and we therefore are delighted to be collaborating with Nestlé, the world’s largest food and beverage company on such an important project. We are really looking forward to beginning this impactful journey together,” says Nora Khaldi, Founder and Chief Scientific Officer of Nuritas.
Richard Stadler, Head of Food Safety and Analytical Science at the Nestlé Research Centre, says: “As our understanding of food and nutrition continues to grow, our global research and development network is looking ahead to discover how we can help enhance quality of life and contribute to a healthier future for everyone. Research partnerships such as that with Nuritas help us achieve that goal.”
“The fruition of our collaboration carries the promise to be truly industry-changing,” says Emmet Browne CEO at Nuritas. “We are very excited to partner with Nestle as they look to continue their own admirable purpose to help shape a better and healthier world.”
Nuritas is a rapidly growing, award-winning digital biotechnology and R&D company which has created remarkable interest globally for its peptide-finding platform capabilities.
Nuritas has received global recognition for the impact its innovative technology will have on the future of food and health. This includes winning the overall Innovation Award at the Forbes Reinventing America Summit in 2015, the Nutrition Capital Network Venture competition in October 2016 and support from EU Horizon 2020 in 2016 for a peptide that carries the potential to prevent prediabetic patients from developing diabetes.
Dr Nora Khaldi, Founder and Chief Scientific Officer of Nuritas, and Emmet Browne, CEO of Nuritas.